TY  - JOUR
AU  - Fuertes, Teresa
AU  - Álvarez-Corrales, Emigdio
AU  - Gómez-Escolar, Carmen
AU  - Ubieto-Capella, Patricia
AU  - Serrano-Navarro, Álvaro
AU  - de Molina, Antonio
AU  - Méndez, Juan
AU  - Ramiro, Almudena R
AU  - de Yébenes, Virginia G
PY  - 2023
DO  - 10.1038/s41419-023-06178-0
UR  - http://hdl.handle.net/20.500.12105/16761
AB  - Diffuse large B cell lymphoma (DLBCL) is the most common aggressive B cell lymphoma and accounts for nearly 40% of cases of B cell non-Hodgkin lymphoma. DLBCL is generally treated with R-CHOP chemotherapy, but many patients do not respond or relapse...
LA  - eng
PB  - Nature Publishing Group
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - MicroRNAs
KW  - Humans
KW  - Neoplasm Recurrence, Local
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Combined Modality Therapy
TI  - miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication.
TY  - journal article
ER  -